Literature DB >> 24285662

Changuinola Virus Serogroup, New Genomes within the Genus Orbivirus (Family Reoviridae) Isolated in the Brazilian Amazon Region.

Sandro P Silva1, Meik Dilcher, Manfred Weidmann, Valéria L Carvalho, Alexandre R Casseb, Eliana V P Silva, Keley N B Nunes, Jannifer O Chiang, Lívia C Martins, Pedro F C Vasconcelos, Márcio R T Nunes.   

Abstract

We report here the first complete genome sequence of a Changuinola virus (CGLV) serotype Irituia virus (BE AN 28873) isolated from a wild rodent (Oryzomys goeldi) in the municipality of Ipixuna, State of Pará, northern Brazil. All genome segments showed similarity with those belonging to members of the genus Orbivirus, family Reoviridae.

Entities:  

Year:  2013        PMID: 24285662      PMCID: PMC3869324          DOI: 10.1128/genomeA.00940-13

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

The genus Orbivirus belongs to the family Reoviridae and includes 22 virus species, as well as 10 unclassified or unassigned viruses (1). Orbiviruses are classified based on their morphological, serological, and physicochemical characteristics (2, 3). They are icosahedral, nonenveloped viruses with double-stranded RNA (dsRNA). Their dsRNA genomes consist of 10 segments coding for 7 structural proteins (VP1 through VP7) and at least 3 nonstructural proteins (NS1 through NS3) (4). The serogroup Changuinola has 12 serotypes: Changuinola virus, Almeirim virus, Altamira virus, Caninde virus, Gurupi virus, Irituia virus, Jamanxi virus, Jari virus, Monte Dourado virus, Ourem virus, Purus virus, and Saraca virus (1). Orbiviruses are transmitted between vertebrate hosts by a variety of arthropod vectors, including midges, ticks, phlebotomine flies, and anopheline and culicine mosquitoes (5). Bluetongue virus (BTV) and African horse sickness virus (AHSV) are the most economically important members of this genus. Several other orbiviruses are potentially important too, such as Equine encephalosis virus (EEV), Epizootic hemorrhagic disease virus (EHDV), Palyam virus (PALV), and Peruvian horse sickness virus (PHSV) (6), while other orbiviruses are causative agents of diseases in humans, such as Kemerovo virus (KEMV) and Tribeč virus (TRBV) (4). The Brazilian CGLV serotype Irituia virus (BE AN 28873) was isolated at the Evandro Chagas Institute, Belém, Brazil, from the blood of a wild rodent species, Oryzomys goeldi, caught on 29 March 1961 in the municipality of Ipixuna, Brazil (3°S 49°W). Antigenic characterization was carried out by complement fixation and neutralization tests (3). Brain tissue of newborn mice infected with serotype Irituia virus was propagated in Vero cells, and after 80% to 90% cytopathic effect (CPE) (3 days postinfection) the supernatant was harvested. Viral particles were concentrated using polyethylene glycol (PEG) centrifugation as previously described (4) and the genomic dsRNA was isolated via a guanidinium isothiocyanate procedure (peqGold Trifast). After DNase treatment to digest cellular DNAs, viral dsRNA was purified from contaminating host single-stranded RNA (ssRNA) by overnight precipitation in 2 M lithium chloride at 4°C as described elsewhere (7). Furthermore, a self-complementary full-length amplification of cDNAs (FLAC) adapter was ligated to the 3′ ends of each RNA segment (8) to be able to cover the termini. The adapter-ligated dsRNA was converted to cDNA, amplified, and fragmented via the TransPlex whole-transcriptome amplification kit as previously described (4). A pyrosequencing library was prepared (9) and used for sequencing on a GS FLX 454 sequencer (Roche, Life Science) at the Department of Virology, University Medical Center, Göttingen, Germany. In parallel, the same library was sequenced in the Center for Technological Innovation at the Evandro Chagas Institute, Ministry of Health, Brazil. The assembly of the obtained sequences was done using the GS de novo Assembler (Newbler v. 2.6). For further analysis, the software Geneious v. 6.1.4 and a set of programs (SeqMan Pro, SeqBuilder, and Protean) available in the DNASTAR package (Lasergene) were used. The coverage of the assembled genome was 1,522-fold. This is the first report for the complete genome sequence of a Brazilian CGLV serotype.

Nucleotide sequence accession numbers.

The complete genome sequence has been deposited in GenBank under the accession numbers KF624614 to KF624623.
  7 in total

1.  Strategies for the sequence determination of viral dsRNA genomes.

Authors:  H Attoui; F Billoir; J F Cantaloube; P Biagini; P de Micco; X de Lamballerie
Journal:  J Virol Methods       Date:  2000-09       Impact factor: 2.014

2.  Genome sequencing in microfabricated high-density picolitre reactors.

Authors:  Marcel Margulies; Michael Egholm; William E Altman; Said Attiya; Joel S Bader; Lisa A Bemben; Jan Berka; Michael S Braverman; Yi-Ju Chen; Zhoutao Chen; Scott B Dewell; Lei Du; Joseph M Fierro; Xavier V Gomes; Brian C Godwin; Wen He; Scott Helgesen; Chun Heen Ho; Chun He Ho; Gerard P Irzyk; Szilveszter C Jando; Maria L I Alenquer; Thomas P Jarvie; Kshama B Jirage; Jong-Bum Kim; James R Knight; Janna R Lanza; John H Leamon; Steven M Lefkowitz; Ming Lei; Jing Li; Kenton L Lohman; Hong Lu; Vinod B Makhijani; Keith E McDade; Michael P McKenna; Eugene W Myers; Elizabeth Nickerson; John R Nobile; Ramona Plant; Bernard P Puc; Michael T Ronan; George T Roth; Gary J Sarkis; Jan Fredrik Simons; John W Simpson; Maithreyan Srinivasan; Karrie R Tartaro; Alexander Tomasz; Kari A Vogt; Greg A Volkmer; Shally H Wang; Yong Wang; Michael P Weiner; Pengguang Yu; Richard F Begley; Jonathan M Rothberg
Journal:  Nature       Date:  2005-07-31       Impact factor: 49.962

3.  Yunnan orbivirus, a new orbivirus species isolated from Culex tritaeniorhynchus mosquitoes in China.

Authors:  Houssam Attoui; Fauziah Mohd Jaafar; Mourad Belhouchet; Nicolas Aldrovandi; Sanju Tao; Boquan Chen; Guodong Liang; Robert B Tesh; Philippe de Micco; Xavier de Lamballerie
Journal:  J Gen Virol       Date:  2005-12       Impact factor: 3.891

4.  Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus--a new taxonomic group. Physiocochemical and serological studies.

Authors:  E C Borden; R E Shope; F A Murphy
Journal:  J Gen Virol       Date:  1971-11       Impact factor: 3.891

5.  Genetic characterization of Tribeč virus and Kemerovo virus, two tick-transmitted human-pathogenic Orbiviruses.

Authors:  Meik Dilcher; Lekbira Hasib; Marcus Lechner; Nicolas Wieseke; Martin Middendorf; Manja Marz; Andrea Koch; Martin Spiegel; Gerhard Dobler; Frank T Hufert; Manfred Weidmann
Journal:  Virology       Date:  2011-12-20       Impact factor: 3.616

Review 6.  Re-emergence of bluetongue, African horse sickness, and other orbivirus diseases.

Authors:  N James Maclachlan; Alan J Guthrie
Journal:  Vet Res       Date:  2010-01-27       Impact factor: 3.683

7.  Rapid cDNA synthesis and sequencing techniques for the genetic study of bluetongue and other dsRNA viruses.

Authors:  Sushila Maan; Shujing Rao; Narender Singh Maan; Simon John Anthony; Houssam Attoui; Alan Richard Samuel; Peter Paul Clement Mertens
Journal:  J Virol Methods       Date:  2007-04-11       Impact factor: 2.014

  7 in total
  2 in total

1.  Genetic and biological characterization of selected Changuinola viruses (Reoviridae, Orbivirus) from Brazil.

Authors:  Sandro P Silva; Meik Dilcher; Franziska Weber; Frank T Hufert; Manfred Weidmann; Jedson F Cardoso; Valéria L Carvalho; Jannifer O Chiang; Lívia C Martins; Clayton P S Lima; Daisy E A Da Silva; João L S G Vianez-Júnior; Vsevolod L Popov; Amélia P A Travassos da Rosa; Robert B Tesh; Pedro F C Vasconcelos; Márcio R T Nunes
Journal:  J Gen Virol       Date:  2014-07-01       Impact factor: 3.891

Review 2.  Exploiting the Legacy of the Arbovirus Hunters.

Authors:  Nikos Vasilakis; Robert B Tesh; Vsevolod L Popov; Steve G Widen; Thomas G Wood; Naomi L Forrester; Jean Paul Gonzalez; Jean Francois Saluzzo; Sergey Alkhovsky; Sai Kit Lam; John S Mackenzie; Peter J Walker
Journal:  Viruses       Date:  2019-05-23       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.